Cardiome Pharma Corporation Pre-Tax Profit Margin 2016-2019 | CORV
Cardiome Pharma Corporation pre-tax profit margin from 2016 to 2019. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2019-09-30 | $0.03B | $-0.04B | -123.33% |
| 2019-06-30 | $0.03B | $-0.03B | -110.00% |
| 2019-03-31 | $0.03B | $-0.02B | -62.07% |
| 2018-12-31 | $0.03B | $-0.02B | -58.62% |
| 2018-09-30 | $0.03B | $-0.02B | -66.67% |
| 2018-06-30 | $0.03B | $-0.02B | -69.23% |
| 2018-03-31 | $0.03B | $-0.03B | -123.08% |
| 2017-12-31 | $0.02B | $-0.03B | -125.00% |
| 2017-09-30 | $0.02B | $-0.03B | -116.67% |
| 2017-06-30 | $0.02B | $-0.03B | -113.04% |
| 2017-03-31 | $0.02B | $-0.02B | -104.35% |
| 2016-12-31 | $0.03B | $-0.02B | -76.00% |
| 2016-09-30 | $0.02B | $-0.02B | -91.30% |
| 2016-06-30 | $0.02B | $-0.02B | -95.65% |
| 2016-03-31 | $0.02B | $-0.02B | -95.65% |
| 2015-12-31 | $0.02B | $-0.03B | -119.05% |
